课题基金 / 基金详情

NTP DATABASE SUMMARIZATION AND EVALUATION

NTP DATABASE SUMMARIZATION AND EVALUATION
NTP数据库总结与评估
批准号:
6289960
负责人:
JOSEPH K HASEMAN
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

JOSEPH K HASEMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The goal of this project is to summarize, evaluate, and interpret data contained in the NTP rodent carcinogenicity database. In addition to publishing updated tumor rates in control Fischer 344 rats and B6C3F1 mice, we identified ten chemicals in the NTP database that increased the incidence of brain tumors in F344 rats. Most of these increases were considered to be equivocal because of the low tumor incidences, and/or the lack of dose response trends. Glycidol was the only chemical evaluated by the NTP for which there was clear evidence of brain tumor induction. Another database evaluation documented the frequency of significant chemically-related decreasing trends in tumor incidence in NTP studies. While the frequency of these decreases exceeds chance expectation, many are related to reduced body weight and/or target organ toxicity in the dosed groups. It was demonstrated that a failure to follow four important scientific principles in a previously published evaluation of the NTP database led to greatly exaggerated frequencies of statistically significant decreasing tumor trends. The factors contributing to these errors included failure to adjust for survival differences, evaluating improper tumor combinations, failure to achieve the reported level of significance (p<0.01), multiply counting the same decreasing tumor effect, and using scientifically inadequate studies. - Rodent carcinogenicity, tumor incidence; brain tumors; transgenic mice, historical control data, decreasing tumor trends
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SOURCES OF VARIABILITY IN TUMOR INCIDENCE IN LONG TERM RODENT STUDIES
NTP DATABASE SUMMARIZATION AND EVALUATION
Identifying /Evaluating Sources Of Variability In Rodent
Identifying And Evaluating Sources Of Variability In Rod
海外基金